A new trading day began on Monday, with ProMIS Neurosciences Inc (NASDAQ: PMN) stock price up 10.20% from the previous day of trading, before settling in for the closing price of $0.5. PMN’s price has ranged from $0.38 to $1.59 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -793.18%. With a float of $18.27 million, this company’s outstanding shares have now reached $32.69 million.
ProMIS Neurosciences Inc (PMN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProMIS Neurosciences Inc is 44.10%, while institutional ownership is 21.86%. The most recent insider transaction that took place on Oct 03 ’25, was worth 14,929. In this transaction Principal Accounting Officer of this company bought 30,392 shares at a rate of $0.49, taking the stock ownership to the 45,389 shares. Before that another transaction happened on Feb 10 ’25, when Company’s Chief Scientific Officer bought 15,000 for $0.97, making the entire transaction worth $14,595. This insider now owns 16,617 shares in total.
ProMIS Neurosciences Inc (PMN) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.43 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -793.18% per share during the next fiscal year.
ProMIS Neurosciences Inc (NASDAQ: PMN) Trading Performance Indicators
Here are ProMIS Neurosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of ProMIS Neurosciences Inc (PMN)
ProMIS Neurosciences Inc (NASDAQ: PMN) saw its 5-day average volume 1.07 million, a negative change from its year-to-date volume of 2.73 million. As of the previous 9 days, the stock’s Stochastic %D was 87.31%.
During the past 100 days, ProMIS Neurosciences Inc’s (PMN) raw stochastic average was set at 13.95%, which indicates a significant decrease from 89.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0355 in the past 14 days, which was lower than the 0.0696 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5402, while its 200-day Moving Average is $0.6565. Nevertheless, the first resistance level for the watch stands at $0.5762 in the near term. At $0.6037, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6392. If the price goes on to break the first support level at $0.5132, it is likely to go to the next support level at $0.4777. Assuming the price breaks the second support level, the third support level stands at $0.4502.
ProMIS Neurosciences Inc (NASDAQ: PMN) Key Stats
With a market capitalization of 28.43 million, the company has a total of 53,811K Shares Outstanding. Currently, annual sales are 0 K while annual income is 2,780 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,120 K.
